Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

HIV infection: epidemiology, pathogenesis, treatment, and prevention.

Author information

Affiliations

  • 1. Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
      Authors
    • Maartens G 1
    (1 author)
  • 2. Departments of Global Health, Medicine and Epidemiology, University of Washington, Seattle, WA, USA.
      Authors
    • Celum C 2
    (1 author)
  • 3. Department of Infectious Diseases, Monash University, Melbourne, Australia; Infectious Diseases Unit, Alfred Hospital, Melbourne, Australia; Centre for Biomedical Research, Burnet Institute, Melbourne, Australia.
      Authors
    • Lewin SR 3
    (1 author)

ORCIDs linked to this article

Lancet (London, England), 05 Jun 2014, 384(9939):258-271
https://doi.org/10.1016/s0140-6736(14)60164-1 PMID: 24907868 

Review

This article has been corrected. See Lancet. 2014 Sep 20;384(9948):1098.

Abstract 

HIV prevalence is increasing worldwide because people on antiretroviral therapy are living longer, although new infections decreased from 3.3 million in 2002, to 2.3 million in 2012. Global AIDS-related deaths peaked at 2.3 million in 2005, and decreased to 1.6 million by 2012. An estimated 9.7 million people in low-income and middle-income countries had started antiretroviral therapy by 2012. New insights into the mechanisms of latent infection and the importance of reservoirs of infection might eventually lead to a cure. The role of immune activation in the pathogenesis of non-AIDS clinical events (major causes of morbidity and mortality in people on antiretroviral therapy) is receiving increased recognition. Breakthroughs in the prevention of HIV important to public health include male medical circumcision, antiretrovirals to prevent mother-to-child transmission, antiretroviral therapy in people with HIV to prevent transmission, and antiretrovirals for pre-exposure prophylaxis. Research into other prevention interventions, notably vaccines and vaginal microbicides, is in progress.

Full text links 

Read article at publisher's site: https://doi.org/10.1016/s0140-6736(14)60164-1

References 

Articles referenced by this article (171)

Show 10 more references (10 of 171)

Citations & impact 

Impact metrics

383
Citations
Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/2404890
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/2404890

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1016/s0140-6736(14)60164-1

Supporting
Mentioning
Contrasting
7
552
1

Article citations

Go to all (383) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.